Evidence map›Paper›PMID 28097097›Full record

ArticleJournal of clinical and translational hepatology2016

miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1.

Mennatallah Mamdouh Mahdy, Nada Magdy El-Ekiaby, Rana Mahmoud Hashish, Radwa Ayman Salah, Rasha Sayed Hanafi, Hassan Mohamed Azzazy, Ahmed Ihab Abdelaziz

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and translational hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Mennatallah Mamdouh MahdyDepartment of Pharmaceutical Chemistry, German University in Cairo, New Cairo City, Egypt.
Nada Magdy El-EkiabyDepartment of Pharmacology and Toxicology, German University in Cairo, New Cairo City, Egypt; School of Medicine, NewGiza University, Cairo, Egypt.
Rana Mahmoud HashishDepartment of Pharmaceutical Biology, German University in Cairo, New Cairo City, Egypt.
Radwa Ayman SalahDepartment of Stem Cells and Regenerative Medicine, Zewail City of Science and Technology, Giza, Egypt.
Rasha Sayed HanafiDepartment of Pharmaceutical Chemistry, German University in Cairo, New Cairo City, Egypt.
Hassan Mohamed AzzazyDepartment of Chemistry, Novel Diagnostic & Therapeutics, American University in Cairo, New Cairo City, Egypt.
Ahmed Ihab AbdelazizDepartment of Pharmacology and Toxicology, German University in Cairo, New Cairo City, Egypt; School of Medicine, NewGiza University, Cairo, Egypt.
German University in Cairo · EGCairo University · EGAmerican University in Cairo · EGZewail City of Science and Technology · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Caveolin-1HCVLipid dropletsMicroRNA-29aSREBP-1c

Identifiers

PMID28097097
PMCPMC5225148
OpenAlexW2582623086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.